Tetrodotoxin and quantitative sensory testing in healthy volunteers

Phase 2

• Conditions: Pain; Signs and Symptoms

• Registration Number: ISRCTN78737401
• Lead Sponsor: eiden University Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-09-20
• Last Update Posted: 3 October 2023
• Study Completion: 2024-03-01

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

1. Aged 18 to 55 years old (inclusive)
2. Body mass index (BMI) within 19-30 kg/m2
3. Subjects will be healthy according to physical examination (including vital signs) and normal laboratory tests (hematology, biochemistry, urinalysis) including, as well as a negative screening of ethyl alcohol and drugs of abuse in urine.

Exclusion Criteria

Not meeting the participant inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Sensation and pain thresholds measured using Quantitative Sensory Testing (QST) after two different doses of Halneuron (Tetrodotoxin (TTX) for Injection)

Secondary Outcome Measures

Name	Time	Method
one provided